Vaccines Against Infectious Diseases
Children aged younger than 5 years. Much of the burden of infectious diseases could be alleviated if appropriate mechanisms could be put in place to ensure access for all children to basic vaccines, regardless of geographical location or economic status. In addition, new safe and effective vaccines should be developed for a variety of infections against which no effective preventive intervention measure is either available or practical. The public, private, and philanthropic sectors need to join forces to ensure that these new or improved vaccines are fully developed and become accessible to the populations in need as quickly as possible Vaccines against infectious diseases are powerful tools for preventing illness, reducing transmission, and saving lives. These vaccines stimulate the immune system to recognize and mount a defense against specific pathogens, such as bacteria or viruses, thereby preventing infection or reducing its severity. Over the years, vaccines have played a crucial role in controlling and eradicating many infectious diseases, leading to significant improvements in public health worldwide.
Related Conference of Vaccines Against Infectious Diseases
9th International Conference on Vaccines, Immunology and Clinical Trials
Vaccines Against Infectious Diseases Conference Speakers
Recommended Sessions
- Animal & Plant Derived Vaccines
- Animal Models & Clinical Trials
- Antibodies: Engineering & Therapeutics
- Cancer, Malaria & TB Vaccines
- Cellular Immunology & Latest Innovations
- Combination & Conjugate Vaccines
- Current Research & Future Challenges
- DNA & Synthetic Vaccines
- Fish & Poultry Vaccines
- Geriatric Immunization
- HIV Vaccines
- Paediatric Vaccination
- Travel & Edible Vaccines
- Vaccine Production & Development
- Vaccine Safety & Efficacy
- Vaccines
- Vaccines & Autism
- Vaccines against Drugs
- Vaccines Against Infectious Diseases
- Vaccines for Immune Mediated Diseases
- Vaccines for Pregnant Women & Neonates
- Vaccines for Unconventional Diseases
- Vectors, Adjuvants & Delivery Systems
- Veterinary Vaccines
Related Journals
Are you interested in
- Advancements in Vaccine Research and Development - Vaccines R&D 2026 (France)
- Advances in Pediatric Vaccines - Vaccines R&D 2026 (France)
- Antimicrobial Resistance (AMR) - VACCINES WORLD 2025 (Germany)
- Bioprocessing and Manufacturing - VACCINES WORLD 2025 (Germany)
- Cancer Vaccines and Immunotherapy - VACCINES WORLD 2025 (Germany)
- Cancer Vaccines and Immunotherapy - Euro Vaccines 2025 (France)
- Childhood Vaccines and Maternal Vaccines - Euro Vaccines 2025 (France)
- Clinical Trials - VACCINES WORLD 2025 (Germany)
- Clinical Trials Design and Methodologies - Vaccines R&D 2026 (France)
- Conjugate Vaccine - VACCINES WORLD 2025 (Germany)
- Coronavirus (COVID-19) & Pandemic Vaccines - VACCINES WORLD 2025 (Germany)
- DNA Vaccines - Euro Vaccines 2025 (France)
- DNA-RNA Vaccines - VACCINES WORLD 2025 (Germany)
- Emerging and Re-Emerging Diseases - VACCINES WORLD 2025 (Germany)
- Emerging Infectious Diseases and Vaccine Development - Vaccines R&D 2026 (France)
- Ethical Considerations in Vaccine Development and Distribution - Vaccines R&D 2026 (France)
- Fungal/Bacterial/Viral/Parasitic/STD Vaccines - VACCINES WORLD 2025 (Germany)
- Global Immunization Strategies and Policy - Vaccines R&D 2026 (France)
- Hepatitis Vaccines - Euro Vaccines 2025 (France)
- HIV Vaccines - VACCINES WORLD 2025 (Germany)
- HIV/AIDS Vaccines - Euro Vaccines 2025 (France)
- Human Preventive & Therapeutic Vaccines - Euro Vaccines 2025 (France)
- Human Vaccines - Infectious & Non Infectious Diseases - Euro Vaccines 2025 (France)
- Immune Profiling - VACCINES WORLD 2025 (Germany)
- Immunology of Infectious Diseases - Vaccines R&D 2026 (France)
- Immunology/Animal Models - Euro Vaccines 2025 (France)
- Immunotherapy and Personalized Medicine - Vaccines R&D 2026 (France)
- Infectious and Non-Infectious Diseases - VACCINES WORLD 2025 (Germany)
- Influenza and Respiratory Vaccines - VACCINES WORLD 2025 (Germany)
- Innovations in Vaccine Cold Chain and Storage - Vaccines R&D 2026 (France)
- Mucosal Vaccines - Euro Vaccines 2025 (France)
- Next-Generation Vaccine Delivery Technologies - Euro Vaccines 2025 (France)
- Regulatory Approaches in Vaccine Development - Vaccines R&D 2026 (France)
- Role of Adjuvants in Vaccine Efficacy - Vaccines R&D 2026 (France)
- Role of AI and Big Data in Vaccine Research - Vaccines R&D 2026 (France)
- Thermo Stabilized Vaccines - VACCINES WORLD 2025 (Germany)
- Translational Immunology and Vaccine Development - Vaccines R&D 2026 (France)
- Vaccine Adjuvants - Euro Vaccines 2025 (France)
- Vaccine Adjuvants - VACCINES WORLD 2025 (Germany)
- Vaccine Delivery Systems: Innovations and Challenges - Vaccines R&D 2026 (France)
- Vaccine Development for Cancer Immunotherapy - Vaccines R&D 2026 (France)
- Vaccine Development for Vector-Borne Diseases - Vaccines R&D 2026 (France)
- Vaccine Equity and Access in Low-Resource Settings - Vaccines R&D 2026 (France)
- Vaccine Hesitancy and Public Perception - Vaccines R&D 2026 (France)
- Vaccine Manufacturing and Distribution - Vaccines R&D 2026 (France)
- Vaccine Production, Supply & Logistics - VACCINES WORLD 2025 (Germany)
- Vaccine Research & Development - Euro Vaccines 2025 (France)
- Vaccine Research and Development - VACCINES WORLD 2025 (Germany)
- Vaccine Safety and Pharmacovigilance - Vaccines R&D 2026 (France)
- Vaccine Safety, Efficacy & Regulatory Affairs - VACCINES WORLD 2025 (Germany)
- Vaccines against Viral and Bacterial Diseases - Euro Vaccines 2025 (France)
- Vaccines Business Development - Euro Vaccines 2025 (France)
- Vaccines for Older Adults - Euro Vaccines 2025 (France)
- Vaccines for Respiratory Diseases - Euro Vaccines 2025 (France)
- Vaccines for Vector-borne Diseases - Euro Vaccines 2025 (France)
- Vaccines Safety & Efficacy - Euro Vaccines 2025 (France)
- Veterinary Vaccine - VACCINES WORLD 2025 (Germany)
- Veterinary Vaccines - Euro Vaccines 2025 (France)